| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/15/1994 | WO1994020086A1 Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof |
| 09/15/1994 | WO1994020073A1 Lipid-polymer conjugates and liposomes |
| 09/15/1994 | WO1994020071A1 Water-in-oil fluid vaccinal emulsions containing a metabolizable oil |
| 09/15/1994 | WO1994020070A1 Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces |
| 09/15/1994 | WO1994020069A1 Pulmonary administration of granulocyte colony stimulating factor |
| 09/15/1994 | WO1994020065A1 Use of trans-urocanic acid as an antioxidant and for the prophylaxis and treatment of ageing of the skin |
| 09/15/1994 | WO1994019942A1 Proteinaceous oil spill dispersant |
| 09/15/1994 | CA2158040A1 Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces |
| 09/15/1994 | CA2157761A1 Use of low density lipoprotein with cytotoxic substances |
| 09/15/1994 | CA2157383A1 Optical isomerization inhibitor |
| 09/15/1994 | CA2157190A1 Crystalline cyclodextrin inclusion complexes of ranitidine hydrochloride and process for their preparation |
| 09/15/1994 | CA2157023A1 Proteinaceous oil spill dispersant |
| 09/15/1994 | CA2134753A1 Cyclodextrin-peptide compositions |
| 09/14/1994 | EP0614914A2 Crosslinked carboxy polysaccharides |
| 09/14/1994 | EP0614886A1 Compound capable of intracerebral residence and use thereof |
| 09/14/1994 | EP0614670A2 Compositions of iodophenoxy alkylene ethers in film-formin materials for visualization of the gastrointestinal tract |
| 09/14/1994 | EP0614669A2 Compositions of iodobenzoic acid derivatives in filmforming materials for visualization of the gastrointestinal tract |
| 09/14/1994 | EP0614666A1 Lyophilized polyalkylene oxide modified protein and polypeptide complexes with cyclodextrin |
| 09/14/1994 | EP0614659A2 Pharmaceutical compositions in semisolid form and a device for administration thereof |
| 09/14/1994 | EP0614527A1 Gel particle contrast media for improved diagnostic imaging |
| 09/14/1994 | EP0614457A1 Leukotriene-b 4? derivatives, process for preparing the same and medicaments. |
| 09/14/1994 | EP0614375A1 Process for the preparation of transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates |
| 09/14/1994 | EP0614374A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 09/14/1994 | EP0614373A1 Oral pharmaceutical composition containing polyethylene glycol immunoglobulin conjugate |
| 09/14/1994 | EP0614370A1 Fibronectin-containing ophthalmic solution, method of manufacture of an ophthalmic solution, method of preserving an ophthalmic solution, and methods of treatment of ophthalmic wounds |
| 09/14/1994 | EP0614358A1 Process and composition for the development of controlled release gemfibrozil dosage form |
| 09/14/1994 | EP0614355A1 Antitumor vaccines |
| 09/14/1994 | EP0585224A4 Monoclonal antibodies which bind to secreted and membrane-bound ige, but not to ige on basophils |
| 09/14/1994 | EP0559738A4 Methods for detection and quantitation of cell subsets within subpopulations of a mixed cell population |
| 09/14/1994 | EP0455735B1 Avidin-biotin assisted immunoassay |
| 09/14/1994 | EP0221176B1 Pharmaceutical vehicles for recucing transdermal flux |
| 09/13/1994 | US5346935 Hydrogel |
| 09/13/1994 | US5346903 Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief |
| 09/13/1994 | US5346886 For increasing chemical stability and penetration of protease inhibitor in the skin |
| 09/13/1994 | US5346703 Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
| 09/13/1994 | US5346702 Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
| 09/13/1994 | US5346701 Transmucosal delivery of macromolecular drugs |
| 09/13/1994 | US5346696 Recombinent Interferon |
| 09/13/1994 | US5346542 Aqueous dispersion of enteric polymers and a method for producing the same |
| 09/12/1994 | CA2116831A1 Compositions of iodobenzoic acid derivatives in film-forming materials for visualization of the gastrointestinal tract |
| 09/12/1994 | CA2115794A1 Compositions of iodophenoxy alkylene ethers in film-forming materials for visualization of the gastrointestinal tract |
| 09/11/1994 | CA2091410A1 Pharmaceutical preparations for the treatment of various viral diseases and cancers |
| 09/08/1994 | DE4405585A1 Use of trans-urocanic acid as antioxidant and for the prophylaxis and treatment of aging skin |
| 09/07/1994 | EP0613951A2 Novel polysaccharides, process for producing polysaccharides, uses of polysaccharides and Azotobacter beijerinckii TNM1 |
| 09/07/1994 | EP0613899A2 Cocaine derivative, protein conjugate thereof, monoclonal antibody producing cell line, method for preparing the cell line and monoclonal antibody |
| 09/07/1994 | EP0613684A1 Solid form xerostomia product |
| 09/07/1994 | EP0613408A1 Developed blank layout angle bracket |
| 09/07/1994 | EP0613379A1 Therapeutic compounds |
| 09/07/1994 | EP0613377A1 Hemostatic composition for local hemostasis |
| 09/07/1994 | EP0613373A1 Risedronate delayed-release compositions |
| 09/07/1994 | EP0613372A1 Subcutaneous implants based on nomegestrol derivatives |
| 09/07/1994 | EP0605477A4 Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media. |
| 09/07/1994 | EP0533809A4 Polyurethane-biopolymer composite |
| 09/07/1994 | CN1091634A Stabilized pharmaceutical compositions comprising an HMG-conreductase inhibitor compound |
| 09/06/1994 | US5344930 Blood substitutes to carry oxygen |
| 09/06/1994 | US5344919 Heterodimeric protein complex; pancreatic cancer diagnosis |
| 09/06/1994 | US5344870 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 09/06/1994 | US5344825 Methanediphosphonic acid formulations with ion exchangers |
| 09/06/1994 | US5344655 External application base or auxiliary agent and external application composition for human being or animal containing the same |
| 09/06/1994 | US5344644 Cytokines or hematopoeitic factors and sulfate groups on mucopolysaccharides |
| 09/06/1994 | US5344640 Preparation of apatite particles for medical diagnostic imaging |
| 09/06/1994 | US5344394 Iontophoretic device incorporating an electrotransport adhesive |
| 09/06/1994 | US5344393 Use of synthetic oxygen carriers to facilitate oxygen delivery |
| 09/06/1994 | CA1331861C Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents |
| 09/01/1994 | WO1994019694A1 Thin film hpmp matrix systems and methods for constructing and displaying ligands |
| 09/01/1994 | WO1994019493A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death |
| 09/01/1994 | WO1994019456A1 Vpr function and activity |
| 09/01/1994 | WO1994019376A1 Polysaccharide derivative and drug carrier |
| 09/01/1994 | WO1994019314A1 Glycerol derivative, device and pharmaceutical composition |
| 09/01/1994 | WO1994019311A1 Polyamine derivatives as radioprotective agents |
| 09/01/1994 | WO1994019021A1 Protein conjugates, compositions containing them and their applications as medicament |
| 09/01/1994 | WO1994019020A1 Excipient stabilization of polypeptides treated with organic solvents |
| 09/01/1994 | WO1994019019A1 Method of preparing colloidal aqueous solutions of active substances which are only slightly soluble in water, and a lipid for use in the method |
| 09/01/1994 | WO1994019018A1 Process for preparing colloidal aqueous solutions of hardly soluble active substances |
| 09/01/1994 | WO1994019007A1 Ribosome inactivating protein compositions having reduced antigenicity |
| 09/01/1994 | WO1994018987A1 Drug composition containing nucleic acid copolymer |
| 09/01/1994 | WO1994018973A1 Bisacodyl dosage form |
| 09/01/1994 | WO1994018960A1 Use of 2-chloro-1-[[4-[(2,6-dichlorophenoxy)methyl]-phenyl]methoxy]-4-methoxy-benzene for the selective treatment of enteroviral infections in humans |
| 09/01/1994 | WO1994018955A1 Compositions for oral delivery of active agents |
| 09/01/1994 | WO1994018954A1 Methods for in vivo delivery of biologics and compositions useful therefor |
| 09/01/1994 | WO1994018951A1 A process for the preparation of substantially alcohol free pharmaceutical compositions |
| 09/01/1994 | WO1994018940A1 Titanium dioxide dispersions, cosmetic compositions and methods for using the same |
| 09/01/1994 | WO1994018935A1 Thickening mixture based on guar gum or non-ionic cellulose and a cross-linked polymer, and cosmetic or dermatological hair- or skin-care composition containing said mixture |
| 09/01/1994 | WO1994018932A1 Light stable color compositions |
| 09/01/1994 | WO1994018925A1 Transmucosal delivery of macromolecular drugs |
| 09/01/1994 | WO1994015637A3 Prevention of suppression of immune defense against cancer caused by the cancer-associated scm-recognition peptides |
| 09/01/1994 | WO1994015587A3 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 09/01/1994 | WO1993012756A3 Transfection of lung via aerosolized transgene delivery |
| 09/01/1994 | CA2157041A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death |
| 09/01/1994 | CA2156916A1 Use of 2-chloro-1¬¬4-(2,6-dichlorophenoxy)methyl|-phenyl|methoxy|- 4-methoxy-benzene for the selective treatment of enteroviral infections in humans |
| 09/01/1994 | CA2155953A1 Protein conjugates, compositions containing them and their applications as medicament |
| 09/01/1994 | CA2151260A1 A process for the preparation of substantially alcohol free pharmaceutical compositions |
| 08/31/1994 | EP0612532A2 Canine coronavirus vaccine from feline enteric coronavirus |
| 08/31/1994 | EP0612530A2 Pharmaceutical preparations containing tumor cytotoxic factor |
| 08/31/1994 | EP0612526A1 Anti-inflammatory and analgesic plaster |
| 08/31/1994 | EP0612520A2 PH-triggered osmotic bursting delivery devices |
| 08/31/1994 | EP0612517A1 Water in oil emulsion for cosmetic or pharmaceutic use |
| 08/31/1994 | EP0612253A1 Adhesive hydrogels having extended use lives and process for the preparation of same |
| 08/31/1994 | EP0612251A1 Stabilised antibodies |
| 08/31/1994 | EP0612249A1 Methods of inhibiting restenosis |